Browsing Tag
clinical trial
34 posts
Smart insulin system improves glucose control for pregnant women with type 1 diabetes, according to ADA 2025 clinical trial findings
Smart insulin system shows improved glucose control in pregnancy with type 1 diabetes, per ADA 2025 trial; regulatory expansion expected. Read full details.
Keymed Biosciences’ CM336 shows sustained remission in AIHA patients after CAR-T failure
Keymed Biosciences’ CM336 delivers 6-month remission in AIHA post-CAR-T failure, with NEJM publication and bullish stock sentiment. Find out what’s next for the biotech.
CStone advances CS5001 clinical trial for first-line DLBCL treatment in Australia
CStone Pharmaceuticals has taken a significant step in the development of its ROR1 antibody-drug conjugate with the submission…
Triastek’s 3D-printed D23 tablet shows strong clinical results for IgAN treatment
Triastek has reported promising clinical results for its 3D-printed drug delivery product, D23 (Budesonide Ileum Targeted Tablets), which…
CARsgen Therapeutics completes enrollment in Phase II trial of Satri-cel for advanced gastric cancer
CARsgen Therapeutics Holdings Limited, a prominent player in the field of CAR T-cell therapies, has announced the successful…
Vimgreen Pharmaceuticals progresses with Phase 2 trial of VG081821AC for Parkinson’s disease
Vimgreen Pharmaceuticals has marked a significant milestone with the completion of participant enrollment in its Phase 2 clinical…
Roche reports setback in lung cancer study with tiragolumab and tecentriq combination
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced disappointing results from the phase II/III SKYSCRAPER-06 study, aimed at…
Dynavax begins clinical trial for new shingles vaccine candidate, Z-1018
Dynavax Technologies Corporation, a renowned player in the biopharmaceutical sector, has made headlines with the initiation of a…
Indivior initiates Phase 2 study for INDV-2000, targeting opioid use disorder with non-opioid treatment
Indivior PLC (LSE/Nasdaq: INDV) has announced the commencement of a Phase 2 clinical trial involving INDV-2000, a non-opioid…
Oxford BioDynamics collaborates with National Cancer Institute in prostate cancer clinical trial
Oxford BioDynamics Plc (AIM: OBD), a pioneering biotechnology company, has announced its participation in a significant clinical trial…